[Severe acute cytomegalovirus colitis after administration of irinotecan and raltitrexed chemotherapy].
Dumortier
Jérôme
J
Villarejo
José
J
Lapalus
Marie-George
MG
Vochelle
Véronique
V
Beatrix
Olivier
O
Scoazec
Jean-Yves
JY
Lombard-Bohas
Catherine
C
D000208:Acute Disease; D000230:Adenocarcinoma / Q000188:drug therapy; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D000998:Antiviral Agents / Q000627:therapeutic use; D002166:Camptothecin / Q000009:adverse effects* / Q000031:analogs & derivatives*; D003092:Colitis / Q000139:chemically induced* / Q000188:drug therapy / Q000276:immunology; D003586:Cytomegalovirus Infections / Q000139:chemically induced* / Q000188:drug therapy / Q000276:immunology; D015774:Ganciclovir / Q000627:therapeutic use; D006801:Humans; D016867:Immunocompromised Host; D000077146:Irinotecan; D008297:Male; D011799:Quinazolines / Q000009:adverse effects*; D012004:Rectal Neoplasms / Q000188:drug therapy; D012811:Sigmoid Neoplasms / Q000188:drug therapy; D013876:Thiophenes / Q000009:adverse effects*
D000964:Antimetabolites, Antineoplastic; D000972:Antineoplastic Agents, Phytogenic; D000998:Antiviral Agents; D011799:Quinazolines; D013876:Thiophenes; D000077146:Irinotecan; C068874:raltitrexed; D015774:Ganciclovir; D002166:Camptothecin
Colite aiguë grave à cytomegalovirus après chimiothérapie par irinotécan et raltitrexed.